Ohio State Navbar

Sign In

RSS Feed Regenerative Medicine News


AxoGen, Inc. Completes $20.8 Million Financing with PDL BioPharma, Inc.  

 

 

AxoGen, Inc. Completes $20.8 Million Financing with PDL BioPharma, Inc. 
October 9, 2012 - (Axogen) - "AxoGen, Inc., and PDL BioPharma, Inc., announced today that they closed a structured financing transaction on October 5, 2012 in which PDL provided AxoGen with an aggregate of $20.8 million. AxoGen is a regenerative medicine company dedicated to advancing the science and commercialization of surgical solutions for peripheral nerve repair."  Read Full Article

 

Posted on 18-Oct-12 by Gallerno, Jacob
Tags: Science and Industry News
 
Trackback Url  |  Link to this post | Bookmark this post with: